Clinical Trial Update: Evaluation of Effectiveness of ALBENDAZOLIVERMECTIN Coformulation vs ALBENDAZOLE for Treatment of Intestinal Worms [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 trial comparing albendazole-ivermectin coformulation to albendazole for intestinal helminth infections has been terminated. Results have been posted…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intestinal Helminthiasis

Drugs mentioned

• Albendazole (ALBENDAZOLE)
• Albendazole-ivermectin coformulation (Albendazole-ivermectin coformulation)
• IVERMECTIN (Ivermectin)

Snippet

Sponsor: Barcelona Institute for Global Health | Conditions: Helminthes; Infestation, Intestinal | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2025-09-22